Daniel Summerfield

Title: The Innovations of Daniel Summerfield: Advancing Collagen Research

Introduction

Daniel Summerfield, an accomplished inventor based in Baltimore, MD, has made significant contributions to the field of biomedical research. With a focused expertise in collagen mimetic peptides, Summerfield holds a patent that promises to enhance both diagnostic and therapeutic applications involving collagen.

Latest Patents

Summerfield's sole patent, titled "Collagen mimetic peptides for targeting collagen strands for in vitro and in vivo imaging and therapeutic use," introduces a novel caged collagen mimetic peptide (CCMP). This invention provides a formula designed to bind collagen and denatured collagen in research settings and clinical applications. The CCMP can target any organ or tissue containing collagen, making it a versatile tool for research and diagnostic imaging, as well as therapeutic use.

Career Highlights

Daniel Summerfield is associated with The Johns Hopkins University, a leading research institution known for its impactful work in various scientific fields. His role there underscores his commitment to advancing medical research and improving diagnostic techniques relating to collagen.

Collaborations

Summerfield collaborates with notable colleagues, including Michael S. Yu and Yang Li, who share his vision for innovation in collagen research. These collaborations contribute to a robust research environment, fostering new ideas and advancing the applications of collagen mimetic peptides.

Conclusion

In summary, Daniel Summerfield's innovations in the realm of collagen mimetic peptides hold tremendous potential for both research and therapeutic applications. His work at The Johns Hopkins University, combined with his collaborations, continues to pave the way for advancements in biomedical imaging and treatment strategies.